ApoE mimetic peptide decreases Aβ production <it>in vitro </it>and <it>in vivo</it>
<p>Abstract</p> <p>Background</p> <p>Apolipoprotein E (apoE) is postulated to affect brain Aβ levels through multiple mechanisms--by altering amyloid precursor protein (APP) processing, Aβ degradation, and Aβ clearance. We previously showed that an apoE-derived peptide...
Main Authors: | Pak Daniel TS, Turner R Scott, Dakshanamurthy Sivanesan, Davis Gary C, Babus Lenard W, Tesoriero Joseph A, Cirrito John R, Cordova Antoinette, Minami S Sakura, Rebeck G William, Paige Mikell, Hoe Hyang-Sook |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-04-01
|
Series: | Molecular Neurodegeneration |
Online Access: | http://www.molecularneurodegeneration.com/content/5/1/16 |
Similar Items
-
Apolipoprotein E decreases tau kinases and phospho-tau levels in primary neurons
by: Hoe Hyang-Sook, et al.
Published: (2006-12-01) -
Connexin-mimetic peptide Gap 27 decreases osteoclastic activity
by: Tuukkanen Juha, et al.
Published: (2001-12-01) -
Retinoic acid mediates regulation of network formation by COUP-TFII and VE-cadherin expression by TGFbeta receptor kinase in breast cancer cells.
by: Priya Prahalad, et al.
Published: (2010-04-01) -
Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease
by: Bosetti Francesca, et al.
Published: (2010-09-01) -
Chronic delivery of a thrombospondin-1 mimetic decreases skeletal muscle capillarity in mice.
by: Gerald N Audet, et al.
Published: (2013-01-01)